These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9918803

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Janus kinase 2 enhances the stability of the mature growth hormone receptor.
    He K, Loesch K, Cowan JW, Li X, Deng L, Wang X, Jiang J, Frank SJ.
    Endocrinology; 2005 Nov; 146(11):4755-65. PubMed ID: 16081639
    [Abstract] [Full Text] [Related]

  • 24. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
    Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C.
    Mol Cell Biol; 1997 Nov; 17(11):6633-44. PubMed ID: 9343427
    [Abstract] [Full Text] [Related]

  • 25. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
    Argetsinger LS, Hsu GW, Myers MG, Billestrup N, White MF, Carter-Su C.
    J Biol Chem; 1995 Jun 16; 270(24):14685-92. PubMed ID: 7782332
    [Abstract] [Full Text] [Related]

  • 26. SH2-B family members differentially regulate JAK family tyrosine kinases.
    O'Brien KB, O'Shea JJ, Carter-Su C.
    J Biol Chem; 2002 Mar 08; 277(10):8673-81. PubMed ID: 11751854
    [Abstract] [Full Text] [Related]

  • 27. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.
    Stred SE, Stubbart JR, Argetsinger LS, Smith WC, Shafer JA, Talamantes F, Carter-Su C.
    Endocrinology; 1992 Mar 08; 130(3):1626-36. PubMed ID: 1537311
    [Abstract] [Full Text] [Related]

  • 28. Determinants of growth hormone receptor down-regulation.
    Deng L, He K, Wang X, Yang N, Thangavel C, Jiang J, Fuchs SY, Frank SJ.
    Mol Endocrinol; 2007 Jul 08; 21(7):1537-51. PubMed ID: 17488973
    [Abstract] [Full Text] [Related]

  • 29. Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice.
    González L, Miquet JG, Sotelo AI, Bartke A, Turyn D.
    Endocrinology; 2002 Feb 08; 143(2):386-94. PubMed ID: 11796490
    [Abstract] [Full Text] [Related]

  • 30. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway.
    Rui L, Archer SF, Argetsinger LS, Carter-Su C.
    J Biol Chem; 2000 Jan 28; 275(4):2885-92. PubMed ID: 10644756
    [Abstract] [Full Text] [Related]

  • 31. Signalling pathway of GH.
    Carter-Su C, King AP, Argetsinger LS, Smit LS, Vanderkuur J, Campbell GS.
    Endocr J; 1996 Oct 28; 43 Suppl():S65-70. PubMed ID: 9076344
    [Abstract] [Full Text] [Related]

  • 32. The identification of JAK2 tyrosine kinase as a signaling molecule for growth hormone.
    Carter-Su C, Argetsinger LS, Campbell GS, Wang X, Ihle J, Witthuhn B.
    Proc Soc Exp Biol Med; 1994 Jul 28; 206(3):210-5. PubMed ID: 7517045
    [Abstract] [Full Text] [Related]

  • 33. Janus kinase 2 influences growth hormone receptor metalloproteolysis.
    Loesch K, Deng L, Cowan JW, Wang X, He K, Jiang J, Black RA, Frank SJ.
    Endocrinology; 2006 Jun 28; 147(6):2839-49. PubMed ID: 16497804
    [Abstract] [Full Text] [Related]

  • 34. Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.
    Wang X, Yang N, Deng L, Li X, Jiang J, Gan Y, Frank SJ.
    Mol Endocrinol; 2009 Apr 28; 23(4):486-96. PubMed ID: 19164446
    [Abstract] [Full Text] [Related]

  • 35. A 40-amino acid segment of the growth hormone receptor cytoplasmic domain is essential for GH-induced tyrosine-phosphorylated cytosolic proteins.
    Wang X, Souza SC, Kelder B, Cioffi JA, Kopchick JJ.
    J Biol Chem; 1995 Mar 17; 270(11):6261-6. PubMed ID: 7534308
    [Abstract] [Full Text] [Related]

  • 36. Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2.
    Alves dos Santos CM, ten Broeke T, Strous GJ.
    J Biol Chem; 2001 Aug 31; 276(35):32635-41. PubMed ID: 11418602
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone signaling pathways.
    Carter-Su C, Schwartz J, Argetsinger LS.
    Growth Horm IGF Res; 2016 Jun 31; 28():11-5. PubMed ID: 26421979
    [Abstract] [Full Text] [Related]

  • 38. Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes.
    Fuhrer DK, Feng GS, Yang YC.
    J Biol Chem; 1995 Oct 20; 270(42):24826-30. PubMed ID: 7559603
    [Abstract] [Full Text] [Related]

  • 39. JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase.
    Kim DW, Cochran BH.
    Mol Cell Biol; 2001 May 20; 21(10):3387-97. PubMed ID: 11313464
    [Abstract] [Full Text] [Related]

  • 40. Fos-Zippered GH Receptor Cytosolic Tails Act as Jak2 Substrates and Signal Transducers.
    Nespital T, van der Velden LM, Mensinga A, van der Vaart ED, Strous GJ.
    Mol Endocrinol; 2016 Mar 20; 30(3):290-301. PubMed ID: 26859362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.